Jon Hamilton
Stories
-
GLP-1 drugs like Ozempic can curb addiction risk, study finds
A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.
-
Scientists make a pocket-sized AI brain with help from monkey neurons
A new study suggests AI systems could be a lot more efficient. Researchers were able to shrink an AI vision model to 1/1000th of its original size.
-
With help from monkeys, scientists build a leaner AI brain
Scientists have created an AI version of a monkey brain that recognizes images without requiring the massive computing power of existing AI systems.
-
This form of mental exercise may cut dementia risk for decades
A study finds that people who did one specific form of brain training in the 1990s were less likely to be diagnosed with dementia over the next 20 years.
-
This complex brain network may explain many of Parkinson's stranger symptoms
Parkinson's disease appears to disrupt a brain network involved in everything from movement to memory.
-
Modest 'mental exercise' can reduce risk of dementia for decades, study finds
One type of cognitive training appears to reduce the risk of dementia 20 years later.
-
Scientists say this brain network may explain range of Parkinson's symptoms
Parkinson's disease can affect sleep, thinking and smell, as well as movement. A new study may explain why.
-
Can the prescription drug leucovorin treat autism? History says, probably not
Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's little evidence the drug will help.
-
A once-obscure cancer drug has become a celebrity in the autism community
The cancer drug leucovorin has been in high demand since the Trump administration endorsed it as a treatment for some autistic kids. Some experts say the drug's popularity has outpaced the science.
-
Brain organoids are helping researchers, but their use also creates unease
Pea-size clusters of human cells called brain organoids inspire both hope and fear. Experts are debating how scientists can responsibly use these bits of gray matter.
